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Introduction
The measurement of T2* has been established as a rapid,
reproducible non-invasive method for assessing iron
loading in the heart and liver. For the heart, two CMR
sequences are used routinely. The first is a 'bright-blood'
multi-echo, single breath-hold acquisition in early sys-
tole. The second 'dark-blood' sequence is acquired in late
diastole with a double inversion-recovery pre-pulse to
null the blood pool giving enhanced blood/myocardial
delineation. The long breath-hold times (up to 20 sec-
onds) can be difficult for some patients, resulting in
impaired image quaility.
Purpose
This study was designed to investigate whether the use of
integrated parallel acquisition techniques (iPAT) to
shorten acquisition times would affect the measurement
of T2* decay.
Methods
65 patients (age 32 ± 16 years, 49% male) undergoing
routine clinical assessment of iron loading were scanned
using a 1.5 T MRI scanner with ECG gating and a cardiac
phased array coil (Siemens Sonata, Erlangen, Germany).
Three separate timed acquisitions (bright-blood cardiac
T2*, dark-blood cardiac T2* and liver T2* sequences)
were performed for each patient both with and without
parallel imaging using GRAPPA (generalised autocalibrat-
ing partial parallel acquisition), iPAT factor 2. T2* decay
was calculated using dedicated software (CMRtools, Car-
diovascular Imaging Solutions, London, UK). Myocardial
T2* was assessed using a region of interest in the septum
of a single mid-ventricular slice. Hepatic T2* was meas-
ured from a region of interest in an area of homogeneous
tissue in a single transverse slice through the liver. Trunca-
tion of the decay curve was used to correct for background
noise. T2* values were compared using a paired, 2-tailed
T test. P values of < 0.05 were defined as significant.
Results
Five patients were excluded from the final analysis due to
artefact which precluded the measurement of T2*.
Although subjectively the images were of inferior quality
when parallel imaging was used, there were no significant
differences in T2* measurement between non-parallel
and parallel sequence acquisitions (see Table 1, 2). The
addition of parallel imaging shortened the breath-hold
times by an average (± SD) of 4.3(2.1), 4.8(2.3) and
4.2(1.6) seconds for bright blood, dark blood and liver
T2* acquisitions respectively (see table 2).
Conclusion
Our results show that parallel imaging using GRAPPA is
able to provide significant time saving for cardiac and
hepatic T2* acquisitions without affecting the measure-
ment of T2* decay. The coefficient of variation observed is
only marginally higher than previously published data on
inter-observer and inter-study variability using breath-
hold sequences without parallel imaging.
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Table 1: Summary of T2* values for each sequence
Sequence Routine acquisition (mean ± 
SD) ms
With parallel imaging (mean 
± SD) ms
P value Coefficient of variation (%)
Cardiac T2* bright blood 29.5 ± 12.6 29.8 ± 12.9 0.37 8.16
Cardiac T2* dark blood 26.02 ± 10.4 26.28 ± 10.6 0.14 5.31
Hepatic T2* 5.7 ± 4.8 5.8 ± 4.6 0.20 4.81
Table 2: Breath-hold times for each sequence
Sequence Routine acquisition (mean ± SD) s With parallel imaging (mean ± SD) s P value
Cardiac T2* bright blood 16.9 ± 3.8 12.2 ± 2.4 < 0.001
Cardiac T2* dark blood 19.8 ± 4.5 14.5 ± 3.3 < 0.001
Hepatic T2* 14.5 ± 1.7 9.8 ± 0.8 < 0.001
Bland-Altman plots (top row) and scatter plots (bottom row) showing comparison of parallel and non-parallel T2* acquisitionsFigure 1
Bland-Altman plots (top row) and scatter plots (bottom row) showing comparison of parallel and non-parallel 
T2* acquisitions.Page 2 of 2
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